Filing Details
- Accession Number:
- 0001104659-15-000899
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2015-01-07 09:48:36
- Reporting Period:
- 2014-12-23
- Filing Date:
- 2015-01-07
- Accepted Time:
- 2015-01-07 09:48:36
- Original Submission Date:
- 2014-12-24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021038 | A Henri Termeer | C/O Verastem, Inc., 117 Kendrick Street, Suite 500 Needham MA 02494 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-12-23 | 15,000 | $8.11 | 32,179 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2014-12-23 | 14,000 | $8.11 | 14,000 | No | 4 | P | Indirect | By wife |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | By wife |
Footnotes
- 6,000 of these shares were omitted from the reporting person's original Form 4.
- 3,900 of these shares were omitted from the reporting person's original Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.
- The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.